RecruitingNot ApplicableNCT06212817
Dietary Fiber Before Colorectal Cancer Surgery
FiberUP in Clinical Practice: Increasing Preoperative Dietary Fiber Intake in Colorectal Cancer Patients.
Sponsor
Wageningen University
Enrollment
54 participants
Start Date
Apr 29, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this randomized controlled trial is to investigate the feasibility of increasing preoperative dietary fiber intake in individuals with colorectal cancer who will undergo surgery. This will be done using 1) digital personalized dietary advice or 2) a dried vegetable product compared to 3) habitual diet (control).
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Age ≥18 years;
- Being diagnosed with CRC and planned to undergo elective CRC resection;
Exclusion Criteria9
- Previously have had a large abdominal resection, excluding appendectomy and cholecystectomy;
- Diagnosed with Crohn's disease, Ulcerative Colitis, Celiac Disease;
- Currently having a stoma;
- Known allergic reactions to plants from the Asteraceae (Compositae) family (e.g., lettuce, daisies, sunflowers, artichokes, sage, tarragon, chamomile, chicory etc.);
- Currently following a strict diet and unwilling or unable to change (e.g., gluten free or ketogenic diet);
- Currently using fiber supplements, prebiotics and/or probiotics and unwilling to stop using these for the duration of the intervention;
- Having a habitual dietary fiber intake \>30 g/day for women and \>40 g/day for men, measured with a food frequency questionnaire;
- Dementia or other cognitive disabilities that makes it impossible to fill out questionnaires correctly;
- Illiteracy (inability to read and understand Dutch).
Interventions
OTHERDietary intervention
Increase dietary fiber intake
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06212817
Related Trials
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
NCT0546403035 locations
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
NCT060775911 location
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
NCT0701157614 locations
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
NCT070717141 location
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations